Patents by Inventor Scott K. Davey

Scott K. Davey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human radioresistance/cell cycle progression gene
    Patent number: 5882862
    Abstract: This invention provides isolated nucleic acids which encode a wildtype and a mutant human homolog of RAD9. This invention also provides purified and mutant wildtype human homologs of RAD9. This invention also provides methods for determining whether a subject has radiosensitivity; for predicting the effect of radiation therapy or chemotherapy on a subject; for detecting whether a subject has a predisposition to cancer; for treating a subject who is radiosensitive and for preventing or treating cancer in a subject who is radiosensitive.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: March 16, 1999
    Assignees: The Trustees of Columbia University in the City of New York, The Ontario Cancer Treatment and Research Foundation
    Inventors: Scott K. Davey, Howard B. Lieberman, Kevin M. Hopkins